The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

It’s a bird, it’s a plane, it’s Super Sub! U-Boat Worx’s just-launched, ruby-red flagship may have more in common with the original 1950s Superman than the color of his cape. The Dutch ...

All patients were followed for 6 months. In the photocoagulation and combined treatment groups, visual acuity did not improve significantly from baseline at any time point studied. The IVTA group ...

Lung cancer survival without treatment is shorter than survival with treatment. People with untreated non-small cell lung cancer—the most common type—typically live between five and 12 months after ...

This isn't an entry-level setup. It includes many of Samsung's high-end tech, including Q Symphony and Dynamic Sound. By Stan Horaczek Posted on Jan 21, 2025 We may earn revenue from the products ...

Although low blood pressure (otherwise known as hypotension) rarely requires treatment, it may need so if there are symptoms like severe dizziness or fainting. The treatment varies by the cause and ...

Treatment for sleep apnea aims to improve your breathing during sleep and reduce the risk of underlying health concerns. Common options include CPAP machines, oral devices, and lifestyle measures ...

Stew Pidd, CEO Subscribers to The Economist can sign up to our new Opinion newsletter, which brings together the best of our leaders, columns, guest essays and reader correspondence.

Immunotherapy, exemplified by Opdivo, enhances cancer treatment by targeting malignant cells using the immune system, offering a more precise approach than traditional therapies. The FDA approved ...

In extending patent protection for its primary cancer medication, Keytruda, Merck (NYSE:MRK) intends to introduce a subcutaneous form of it this year. It's important to also note that Merck is ...